Status | Study |
Recruiting |
Study Name: Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU Condition: Hemolytic Uremic Syndrome of Childhood Date: 2014-07-28 Interventions: Drug: Eculizumab |
Recruiting |
Study Name: Immunopathology of Autoimmune Hemolytic Anemia Condition: Autoimmune Hemolytic Anemia Date: 2014-03-05 Interventions: Biological: blood samples |
Completed |
Study Name: A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome (aHUS) Date: 2012-11-13 |
Recruiting |
Study Name: R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions Condition: Hemolysis Date: 2012-03-16 |
Recruiting |
Study Name: An Open Label Study of the Effects of Eculizumab in CD59 Deficiency Condition: Chronic Hemolysis Date: 2012-02-23 Interventions: Drug: Eculizumab PNH and or atypical TTP classical protocols |
Recruiting |
Study Name: Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry Condition: Atypical Hemolytic-Uremic Syndrome Date: 2012-01-18 |
Completed |
Study Name: A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia Condition: Autoimmune Hemolytic Disease (Cold Type) (Warm Type) Date: 2011-04-28 Interventions: Drug: prednisone, low dose rituximab Patients with "w |
Completed |
Study Name: Hemolysis in Patients With Hereditary Spherocytosis (HS) Condition: Hereditary Hemolysis Date: 2010-09-12 Interventions: Other: fermented papaya preparation (FPP) Hemolysis will be assayed by suspending 3 ml of packed RBC in |
Completed |
Study Name: An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome Condition: Atypical Hemolytic-Uremic Syndrome Date: 2010-08-31 Interventions: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Study Name: An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome Condition: Atypical Hemolytic-Uremic Syndrome Date: 2010-08-31 Interventions: Drug: Eculizumab Fixed dosing is based on body weight cohorts. Adjustment of dose to accommodate patient |